We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avacta | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.00 | -3.77% | 51.00 | 50.00 | 52.00 | 52.50 | 50.00 | 52.50 | 1,560,753 | 10:28:22 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 23.25M | -24.95M | -0.0695 | -7.34 | 190.29M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/2/2024 09:14 | I increased my short two days ago, as it was so obvious it was coming, the price action told you that. Sorry for all longs who listened to those that said there was no placing coming, always better to go with your gut feeling. | the cronk | |
29/2/2024 09:13 | Imo share price is going nowhere bcz continues dilution through death spiral loan | hamidahamida | |
29/2/2024 09:10 | 10p in 6 months | epifanio1 | |
29/2/2024 09:08 | Funny how the rampers always disappear when they get it wrong. I do wish people would listen to the downside arguments more as they are usually right a lot more often. It's just the way aim and small caps have always been. 90 plus percwbt will lose pis money that's a fact so it's always mot likely the negatives will become relaity rather than the rampers ill founded optomismm. | bones698 | |
29/2/2024 09:07 | Good points re Affimers A team was formed to purchase diagnostics companies, the last just 8 months ago. Now a farcical plan to sell them. Why??? The plan was to get a route an established market through which they could channel their own diagnostics. So it seems that news effectively is saying they have abandoned their own diagnostics, IE a failure, which they failed to mention prior, but should have. | ohwhatfun | |
29/2/2024 09:04 | Yes I reckon most of the shares were foward sold ages ago when the share price was over 100 p, all the City of London Barrow Boys and insiders would have known a placing was coming. The 50 p is now for the IIs and MMs to cover their shorts, I bet you don't see any new TR-1s. The thing is now that after the Diagnostics debacle and now this half price placing no-one with any brain will trust anything Smiffy says ever again, I haven't since they 'temporarily paused' the best LFT in the world (allegedly). He and the CFO and the Chairman need to to. Now how much further dilution do you think is coming now that the death spiral payday loan will be converting at something like half what it was originally set at? How long will it take to churn all those shares in a company with one drug in Phase 1 CT that's lost trust on AIM? | 1347 | |
29/2/2024 08:59 | AIMSCUM! Very erudite | fieldhouse | |
29/2/2024 08:54 | atmysignal 28 Feb '24 - 18:28 - 57115 of 57146 0 0 0 Mega bounce tomorrow 13% short need to close >>>>> 🤣🤣 | papillon | |
29/2/2024 08:47 | With a mkt cap of 150m even now I wouldn't say the worst is over either. A lot of trust will be gone and now it will be a case of show us the money before people even think of touching this. As usual pis get shafted for management's failures. I hope it turns out different but its a very familiar scenario especially for small cap biotechs Won't be surprised to see this at 20-30p in a few months tbh that's just how this sector is atm and fund raising kills off any value. Death spiral financing unfortunately | bones698 | |
29/2/2024 08:46 | Could well go sub 50 p unless the corrupt market can stop it. | 1347 | |
29/2/2024 08:44 | Told you 50p total scam share . You have to be mad to buy this 99% never come to commercial viability. These shares have already been sold into market . Rinse repeat | aimscam1 | |
29/2/2024 08:36 | Can't disagree Aman !! | fieldhouse | |
29/2/2024 08:33 | Add to that if the CEO says don't worry about future funding take it as a merry quip, not to be taken seriously | sandcrab2 | |
29/2/2024 08:32 | This will be stuck around 50p until they can prove they can deliver now. For me it's still way overvalued compared to other companies in the sector but at least they didn't wait to long for the fund raise otherwise would have got even worse. Mkt cap still looks scary though so don't be surlrised if it flaps further imo | bones698 | |
29/2/2024 08:25 | A nasty raise for all unless you.re a first timer at 50p. Way too many gullible pi.s in the mire now, led like lemmings to the cliff edge, and shoved off. If you take the following things away from this ,you.ve learned.a/ Do not trust inexperienced blog posters. b/ No real revenue stream equals raises.c/ Time lags, slow news releases ,are often a killer.d/ Convis are bldy awful as I.ve said time and time again. They knack future fund raises- destroys the share price e/ Bank profits when you can.f/ Spread your cash over 4-8 shares - offers some protection.g/ If it sounds too good to be true it probs is.h/ Bias confirmation is deadly. Read Ken Fischers oldish books.i / Hindsight is always the gift that keeps giving.GLA... | amanitaangelicus | |
29/2/2024 08:25 | You were warned | bones698 | |
29/2/2024 08:21 | Whats happening. | blueball | |
29/2/2024 08:20 | And no more convertible bond. sell the DX and extend the cash runway | fieldhouse | |
29/2/2024 08:16 | Well,the TA played out !! Institutions lapped up shares at 50p. extended offer-directors doubled their original allotment ! Science still good--time line extended-- widened use of platform---time bought to prove efficacy - | fieldhouse | |
29/2/2024 08:16 | No bounce. Trust has been eroded. | countbasie1 | |
29/2/2024 08:10 | Never invest in small biopharma unless you want to lose money. The list of disasters is miles long ( pun intended) | volsung | |
29/2/2024 08:10 | Glad switched to APH few weeks ago | blackhorse23 | |
29/2/2024 08:09 | Placing every year , share price will drop below 10p | blackhorse23 | |
29/2/2024 08:07 | Bought some at 51.5pTrade only | beatme1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions